| 0 (0%) | 11-30 07:30 | |||||||||||||
|
|
| Short term | ||||
| Mid term | |
|||
| Targets | 6-month : | 27.49 |
1-year : | 30.36 |
| Resists | First : | 23.53 |
Second : | 26 |
| Pivot price | 22.79 |
|||
| Supports | First : | 19.54 |
Second : | 16.26 |
| MAs | MA(5) : | 22.17 |
MA(20) : | 22.96 |
| MA(100) : | 18.18 |
MA(250) : | 12.28 |
|
| MACD | MACD : | 0.5 |
Signal : | 0.8 |
| %K %D | K(14,3) : | 50.6 |
D(3) : | 38 |
| RSI | RSI(14): 49.6 |
|||
| 52-week | High : | 29 | Low : | 3.68 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ VHC ] has closed above bottom band by 26.7%. Bollinger Bands are 36.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 23.86 - 23.97 | 23.97 - 24.07 |
| Low: | 22.06 - 22.19 | 22.19 - 22.31 |
| Close: | 23.59 - 23.81 | 23.81 - 24.02 |
Wed, 26 Nov 2025
Insider Sale: Director at $VHC Sells 1,875 Shares - Quiver Quantitative
Wed, 26 Nov 2025
Feiner Gary sells VirnetX (VHC) shares worth $42562 - Investing.com
Wed, 26 Nov 2025
VirnetX (NYSE:VHC) Stock Price Crosses Above 200 Day Moving Average - What's Next? - MarketBeat
Thu, 20 Nov 2025
Nanox to acquire VHC IT to accelerate AI deployment in US - Yahoo Finance
Fri, 07 Nov 2025
VHC Health expands Tysons facility with imaging, women’s health services - FFXnow
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | -14 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 4.27e+006 (%) |
| Held by Institutions | 3.66e+006 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 50000 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -4.79 |
| Profit Margin | 0 % |
| Operating Margin | -8 % |
| Return on Assets (ttm) | 216.6 % |
| Return on Equity (ttm) | -23.7 % |
| Qtrly Rev. Growth | 50000 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -23.9 |
| EBITDA (p.s.) | 1807.22 |
| Qtrly Earnings Growth | -1.902e+007 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | -4.58 |
| Price to Sales | -0.92 |
| Price to Cash Flow | 0 |
| Dividend | 147780 |
| Forward Dividend | 123320 |
| Dividend Yield | 676339% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |